InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Silver Brian M., Chief Financial Officer. Officer active across 1 companies, notably TScan Therapeutics, Inc.. In total, 7 reports have been recorded. Total volume traded: €210k. The latest transaction was filed on 24 March 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
€46,32115,000 shares@ €3.0880.071% mcap22.0% of flow
Voting Common Stock
SEC:0000899243-22-012476:0·
Ideal exit: 19 Dec 2022 (T+270)
€26,9435,000 shares@ €5.38860.041% mcap32.9% of flow
Voting Common Stock
SEC:0000899243-21-037149·
Ideal exit: 18 Jun 2022 (T+270)
€26,9435,000 shares@ €5.38860.041% mcap12.8% of flow
Voting Common Stock
SEC:0000899243-21-037149:0·
Ideal exit: 18 Jun 2022 (T+270)
€42,2175,885 shares@ €7.17360.065% mcap51.6% of flow
Voting Common Stock
SEC:0000899243-21-035684·
Ideal exit: 6 Jun 2022 (T+270)
€42,2175,885 shares@ €7.17360.065% mcap20.1% of flow
Voting Common Stock
SEC:0000899243-21-035684:0·
Ideal exit: 6 Jun 2022 (T+270)
€12,7291,000 shares@ €12.7290.019% mcap15.5% of flow
Voting Common Stock
SEC:0000899243-21-029437·
Ideal exit: 16 Apr 2022 (T+270)
€12,7291,000 shares@ €12.7290.019% mcap6.1% of flow
Voting Common Stock
SEC:0000899243-21-029437:0·
Ideal exit: 16 Apr 2022 (T+270)
7 of 7 declarations
About Silver Brian M.
Silver Brian M. is the Chief Financial Officer of TScan Therapeutics, Inc. As CFO, he oversees the financial operations of the company, including financial planning and risk management. His expertise is essential in ensuring the financial stability of the organization.
